Context Therapeutics Inc.(CNTX)

Biotechnology · Philadelphia, PA

$0.35+0.01 (+4.13%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T14:11:25.184Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:11:25.184Z.

Quote observation: 2026-10-06T14:10:18.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -33,970,930
Quote market capitalization: 32,194,464

FMP input reference: c88c4f39e0f2b8ce509c05ad310ef4a925915372bb385716b1b31bbca6f45484

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CNTX Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

CNTX Competitors' Operating Cash Flow Yield

CNTX

Context Therapeutics Inc.

Current

Market Cap

$32.19M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs CNTX

Market Cap

$33.24M

Operating Cash Flow Yield

N/A

TTM Avg

0.20%

3Y Avg

0.20%

5Y Avg

0.20%

ALGS

Aligos Therapeutics, Inc.

vs CNTX

Market Cap

$32.92M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIRA

MIRA Pharmaceuticals, Inc.

vs CNTX

Market Cap

$31.62M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BYSI

BeyondSpring Inc.

vs CNTX

Market Cap

$31.46M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BEAT

HeartBeam, Inc.

vs CNTX

Market Cap

$33.31M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BDMD

Baird Medical Investment Holdings Limited

vs CNTX

Market Cap

$31.23M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXH

MDxHealth S.A.

vs CNTX

Market Cap

$30.86M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRCE

Grace Therapeutics, Inc.

vs CNTX

Market Cap

$34.01M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRVO

CervoMed Inc.

vs CNTX

Market Cap

$29.63M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Context Therapeutics Inc. (CNTX)	$32.19M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$33.24M	N/A	0.20%	0.20%	0.20%
Aligos Therapeutics, Inc. (ALGS)vs ›	$32.92M	N/A	N/A	N/A	N/A
MIRA Pharmaceuticals, Inc. (MIRA)vs ›	$31.62M	N/A	N/A	N/A	N/A
BeyondSpring Inc. (BYSI)vs ›	$31.46M	N/A	N/A	N/A	N/A
HeartBeam, Inc. (BEAT)vs ›	$33.31M	N/A	N/A	N/A	N/A
Baird Medical Investment Holdings Limited (BDMD)vs ›	$31.23M	N/A	N/A	N/A	N/A
MDxHealth S.A. (MDXH)vs ›	$30.86M	N/A	N/A	N/A	N/A
Grace Therapeutics, Inc. (GRCE)vs ›	$34.01M	N/A	N/A	N/A	N/A
CervoMed Inc. (CRVO)vs ›	$29.63M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

CNTX Operating Cash Flow Yield Metrics

CNTX Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics